Recent Funding
Investors
Canaan Partners

Canaan Partners portfolio

Canaan Partners has 33 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Website: canaan.com.

Type: Venture capital.

Portfolio on Recent Funding: 33.

Deals, last 12 months: 1.

Rounds led: 16 of 36.

Capital in their rounds: $2.68B.

Latest deal: Setara Biosciences · Oct 30, 2026.

About this page

It is a venture capital firm based in Stamford, US, founded in 1987. It led 16 of the 36 rounds it joined. Its most recent investment on record is Setara Biosciences's $90M Series A round in October 2026, alongside EcoR1 Capital, Euclidean Capital, Jazz Pharmaceuticals and 3 others. By category, its portfolio leans toward Health and bio (9) and Media and content (5). It has co-invested with Eurazeo, SoftBank Vision Fund and Highland Europe, most often Eurazeo (5 rounds).

About Canaan Partners

Firm type: Venture capital.

Headquarters: Stamford, US.

Founded: 1987.

Stages: Pre-Seed, Seed, Series A.

Sectors: Biotech, Cloud Computing, Consumer, Deep Tech, Digital Health, E-commerce, Enterprise Software, Fintech, Gaming, Healthtech, Medical Devices.

Check size: $500K to $20M.

Leads rounds: Yes.

Portfolio companies: 370.

Exits: 103.

Rounds led: 42.

Fund returns

Fund	Vintage	Size	Net IRR	TVPI	DPI	As of
Canaan XIII Healthcare Fund L.P.	2024	—	—	0.59x	0.00x	Jun 30, 2025
Canaan XIII L.P.	2024	—	—	0.90x	0.01x	Jun 30, 2025
Canaan Gold Coast L.P.	2023	—	—	1.03x	0.00x	Jun 30, 2025
Canaan XII L.P.	2020	—	3.4%	1.10x	0.00x	Sep 30, 2025
Canaan XI, L.P.	2017	—	9.7%	1.68x	0.06x	Sep 30, 2025
Canaan IX	2012	—	19.1%	2.04x	0.93x	Jun 30, 2020
Canaan VIII, L.P.	2007	—	8.9%	1.44x	1.24x	Jun 30, 2020
Canaan Equity Partners VII	2005	—	16.0%	2.44x	1.50x	Jun 30, 2016
Canaan VII, L.P.	2005	—	14.6%	2.53x	2.33x	Sep 30, 2025

Funds raised

Fund	Fund #	Size	Announced
CCanaan Partners	X	$675M	Oct 16, 2014 FierceBiotech

What Canaan Partners invests in

Canaan Partners recent investments

Company	Round	Date	Alongside
SSetara Biosciences	Series A · $90M	Oct 30, 2026	EcoR1 Capital, Euclidean Capital, Jazz Pharmaceuticals +3
AActio Biosciences	Series B+ · $66M	Jun 18, 2025	Euclidean Capital, Droia Ventures, Regeneron Ventures (lead) +1
CCynomi	Series B+ · $37M	Apr 23, 2025	Flint Capital, s16vc, Entrée Capital (lead) +1
EEnterpret	Series A · $20.8M · lead	Dec 4, 2024	none named
QQuantum Circuits	Series B+ · $60M	Aug 16, 2024	Connecticut Innovations, OUP, Hither Creek Ventures (lead) +6
CCatalYm	Series B+ · $150M · lead	Jul 16, 2024	Gilde Healthcare, Forbion Capital Partners, Novartis Venture Fund +5
GGrey Wolf Therapeutics	Series B+ · $50M	May 23, 2024	Intermediate Capital Group (lead), Pfizer Venture Investments, British Patient Capital +3
CCynomi	Series A · $20M · lead	Apr 17, 2024	Flint Capital, Aloniq, s16vc

How Canaan Partners invests

Stage	Deals	Capital in rounds
Series B+	21 58%	$2.21B
Series A	13 36%	$465.3M
Seed	2 6%	$6.3M

Year	Deals	Capital in rounds
2017	2 6%	$58M
2018	1 3%	$42M
2019	5 14%	$93M
2020	5 14%	$424.5M
2021	6 17%	$840M
2022	5 14%	$598M
2023	2 6%	$104M
2024	7 19%	$324.1M
2025	2 6%	$103M
2026	1 3%	$90M

Company	Round with Canaan Partners	Total raised	Latest raise
SSetara Biosciences Health and bio	Oct 30, 2026 Series A · $90M	$90M	Oct 30, 2026 Series A
AActio Biosciences Health and bio	Jun 18, 2025 Series B+ · $66M	$121M	Jun 18, 2025 Series B+
CCynomi Cybersecurity	Apr 23, 2025 Series B+ · $37M	$60.5M	Apr 23, 2025 Series B+
EEnterpret Data and analytics	Dec 4, 2024 Series A · $20.8M · lead	$25.1M	Dec 4, 2024 Series A
QQuantum Circuits Robotics and hardware	Aug 16, 2024 Series B+ · $60M	$78M	Aug 16, 2024 Series B+
CCatalYm Health and bio	Jul 16, 2024 Series B+ · $150M · lead	$259.04M	Jul 16, 2024 Series B+
GGrey Wolf Therapeutics Health and bio	May 23, 2024 Series B+ · $50M	$99M	May 23, 2024 Series B+
LLily AI Commerce and retail	Apr 14, 2024 Series B+ · $20M	$59.5M	Apr 14, 2024 Series B+
AArtie Data and analytics	Feb 14, 2024 Seed · $3.3M	$15.8M	Jan 22, 2026 Series A
NNormunity Health and bio	Oct 25, 2022 Series A · $65M · lead	$140M	Jan 13, 2025 Series B+
CContentSquare Voice and audio AI	Jul 20, 2022 Series B+ · $400M	$1.21B	Jul 20, 2022 Series B+
AAppsmith	Jun 23, 2022 Series B+ · $41M	$41M	Mar 10, 2025 Seed
RRondo Therapeutics Health and bio	Mar 2, 2022 Series A · $67M · lead	$67M	Mar 2, 2022 Series A
NnTopology Manufacturing and industrial	Nov 18, 2021 Series B+ · $65M	$125M	Nov 18, 2021 Series B+
PPapa Health and bio	Nov 4, 2021 Series B+ · $150M	$220M	Apr 25, 2025 Series B+
MMindTickle Sales and marketing	Aug 1, 2021 Series B+ · $100M	$254.8M	Aug 1, 2024 Series B+
TTropic Sales and marketing	Aug 1, 2021 Series A · $25M · lead	$67M	Feb 1, 2022 Series B+
SSynthekine Health and bio	Sep 1, 2020 Series A · $82M · lead	$290M	Jan 6, 2023 Series B+
PPlayers' Lounge Gaming	Mar 28, 2019 Seed · $3M	$13.5M	Sep 14, 2022 Series A
MMosey Fintech	backer · source	$18M	Aug 4, 2022 Series A
IItalic Commerce and retail	backer · source	$15M	Aug 17, 2025 Series B+
FFireflies Voice and audio AI	backer · source	undisclosed	—
DDoorstep Logistics and mobility	backer · source	$8M	Sep 25, 2025 Seed
OOpenArt Consumer and social	backer	$5M	Jan 30, 2026 Series A
FField AI Robotics and hardware	backer	undisclosed	Aug 20, 2025 round
DDraig Therapeutics Health and bio	backer	$205M	Jul 14, 2026 Series B+
RRylo Voice and audio AI	backer	$85M	Jun 9, 2026 Series B+
SSumble Sales and marketing	backer	$38.5M	Oct 22, 2025 round
HHeyMilo AI AI agents	backer	undisclosed	Mar 3, 2025 Seed
JJumpcut Education	backer	undisclosed	—
EEmbroker Insurance	backer	undisclosed	—
CCompstak Real estate and construction	backer	undisclosed	—
BBalloon	backer	undisclosed	—

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Net returns as reported by the public-pension and foundation LPs invested in each fund.

Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Venture funds Canaan Partners raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

Share is of the 36 rounds on Recent Funding that name Canaan Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Canaan Partners, which is a subset of its real portfolio. API: /api/v1/investors/canaan-partners (get a free API key). More: the most active VC firms and new venture capital funds.